Contract 75N91022F00002
The Univeristy Of Texas M.D. Anderson Cancer Center · Department Of Health And Human Services · October 8, 2021
The Univeristy Of Texas M.D. Anderson Cancer Center was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on October 8, 2021 for $54.88 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Houston, TX. This is a task or delivery order issued under parent IDIQ 75N91019D00021. The contract has been modified 106 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 8, 2026.
Contract details
- PIID
- 75N91022F00002
- Parent IDIQ
- 75N91019D00021
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Houston, TX
- First action
- October 8, 2021
- Latest action
- April 8, 2026
Description
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINTS BIOMARKERS TASK ORDER TITLE: TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATI
Modification timeline
-
April 8, 2026Mod P00004PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINTS BIOMARKERS TASK ORDER TITLE: TARGETING STAT3 TO PREVENT NO$0
-
February 11, 2026Mod P00008DEVELOPMENT, PRODUCTION, AND DISSEMINATION OF NCI TOBACCO CONTROL MONOGRAPH$0
-
January 13, 2026Mod P00003TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE$0
-
November 24, 2025Mod P00006BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION$0
-
July 18, 2025Mod P00003PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)$1.23M
-
July 14, 2025Mod P00005BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION$0
-
July 14, 2025Mod P00004NUCLEIC ACID EXTRACTIONS FOR DCEG STUDIES$53.1K
-
June 13, 2025Mod P00003VRC RAPID MANUFACTURING RESPONSE: NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT$0
-
June 12, 2025Mod P00004TASK ORDER 4A SITE STUDY SETUP: CANCER TRIALS SUPPORT UNIT (CTSU) IDIQ$1.54M
-
June 2, 2025Mod P00001EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91022F00002?
Contract 75N91022F00002 is a federal contract awarded to The Univeristy Of Texas M.D. Anderson Cancer Center by Department Of Health And Human Services on October 8, 2021 for $54.88 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 106 times since the base award.
Who won contract 75N91022F00002?
The Univeristy Of Texas M.D. Anderson Cancer Center won contract 75N91022F00002 from Department Of Health And Human Services.
How much is contract 75N91022F00002 worth?
Contract 75N91022F00002 has obligated $54.88 million to date.